Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hughes, TP
  • Leber, Brian
  • Cervantes, F
  • Spector, N
  • Pasquini, R
  • Clementino, NCD
  • Schwarer, AP
  • Dorlhiac-Llacer, PE
  • Mahon, F-X
  • Rea, D
  • Guerci-Bresler, A
  • Kamel-Reid, S
  • Bendit, I
  • Acharya, S
  • Glynos, T
  • Dalal, D
  • Branford, S
  • Lipton, JH

publication date

  • November 2017